The Spanish Government will invest close to $29.4 million (€26 million) in the expansion or renovation of a total of 34 high-tech equipment in public health centers in Castilla-La Mancha, thanks to the High Technology Investment Plan (Inveat).
That was announced by the Minister of Health, Carolina Darias, who visited this Thursday, January 20th, together with the Minister of Health of Castilla-La Mancha, Jesús Fernández Sanz, and the Managing Director of the Health Service of Castilla-La Mancha (Sescam), Regina Leal, the facilities of the General University Hospital of Ciudad Real. This is one of the healthcare centers in the autonomous community that are beneficiaries of the Inveat Plan.
Born2Invest’s team of journalists gathers the most interesting business news in a single mobile application. It’s impossible to keep up with everything you’re interested in, but our companion app will help you keep track of the important news. Our app is being updated throughout the day.
The Health MInister will renew, with this plan, linear accelerators, CT or MRI
The Minister reminded that the Inveat Plan will involve an overall investment of more than $900.5 million (€795 million) throughout Spain, which will enable the renewal of 585 pieces of equipment in the National Health System’s (SNS) technology pool and the expansion of a further 262.
In total, Inveat, which represents the largest investment under the Ministry of Health’s Recovery, Transformation and Resilience Plan, will facilitate the renewal or expansion of around 850 pieces of equipment in the public healthcare technology pool throughout the country.
As the Minister of Health pointed out, this is “an unprecedented investment in the Spanish healthcare system”, which will make it possible to improve the diagnostic and therapeutic capacity of the SNS; in particular, Darias stressed, giving as an example that the two new PET-CT scanners to be installed with these funds at the Hospital General Universitario de Ciudad Real “will make it possible to double the number of patients to be diagnosed, that is, to go from 9,000 people per year to 18,000 and to increase the number of patients per year to 18,000,” she said. 000 people a year to 18,000 and to reduce the radiation dose by 50%.
The portfolio of equipment to be renewed or expanded includes linear accelerators, CT scanners, magnetic resonance imaging, PET-CT, gamma cameras, digital brachytherapy equipment, vascular angiographs, neuroradiology angiographs, and hemodynamics rooms. It should be noted that, thanks to these investments, the obsolescence of the high-tech equipment in the SNS will be reduced and the average density rate of high-tech equipment per 100,000 inhabitants will be increased by at least 15%.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Spain Scores Better than its European Neighbors in ESG
Despite being a universe of rising assets, the war in Ukraine and the withdrawal of stimulus by central banks has...
Tourism Revenues in Morocco Started to Increase
Tourism revenues amounted to $960,000 (9.7 MMDH) at the end of March 2022 after the context of tourism recovery. Prior...
Tenuta Liliana Vineyard Opens Up to Popular Shareholding on CrowdFundMe
The newly built winery of Tenuta Liliana was created inside a former tuff quarry, reclaimed and completely regenerated, and houses...
Avalanche Price Forecast: AVAX Forms a Dangerous Pattern
In the four-hour chart, the AVAX price has been moving in a tight range over the past few days. A...
First Closing of €95M for Bio, Indaco’s New Fund Dedicated to Biotech and Pharma
Indac's new fund, Indaco Bio is focused on Italy, but will not lack significant room for investments abroad, particularly in...
Cannabis2 weeks ago
Why the Cannabis Market Has Growing Investment Prospects
Featured2 weeks ago
Understanding the Fed’s Rate Hike: the Long Term Goal of 2.0% Inflation
Business2 weeks ago
These Are the Top 5 Lithium Stocks to Own Right Now
Crypto2 weeks ago
Kraken Opens a Waiting List for the Upcoming NFT Marketplace